Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.
about
Circumventing antivector immunity: potential use of nonhuman adenoviral vectorsReplication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsArming oncolytic viruses to leverage antitumor immunity.Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.Tumor ablation by intratumoral Ra-224-loaded wires induces anti-tumor immunity against experimental metastatic tumors.Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice.Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1.Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis.Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.
P2860
Q26995655-0FD6D816-57B8-4177-9289-FD78797BE155Q28559652-EB43FA56-3B0B-4005-BF87-AC7367A99318Q38470166-7191931A-7D75-49E9-8B64-F5DE520AAFECQ38618197-77A4F050-EB9F-4FDA-8B8D-DBF7D9DD689FQ38946861-92724E1E-5B59-4673-BDF7-A94A72F83C43Q39298850-B22E9F55-F0D1-476D-B357-69404310929EQ40385301-D4B0C15B-6C9C-4BC3-829E-3C932F74089FQ47547236-D2115755-35C2-47AA-8416-0CF97C12ADA2Q47564266-43F7FE96-9EAB-44B0-83E8-EAD578A472C6
P2860
Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel immunocompetent murine t ...... ic) murine adenoviral vectors.
@en
Novel immunocompetent murine t ...... tionally replication-competent
@nl
type
label
Novel immunocompetent murine t ...... ic) murine adenoviral vectors.
@en
Novel immunocompetent murine t ...... tionally replication-competent
@nl
prefLabel
Novel immunocompetent murine t ...... ic) murine adenoviral vectors.
@en
Novel immunocompetent murine t ...... tionally replication-competent
@nl
P2093
P2860
P356
P1433
P1476
Novel immunocompetent murine t ...... ic) murine adenoviral vectors.
@en
P2093
Karin Jooss
Katherine R Spindler
Melinda VanRoey
Michael Robinson
Satya Yendluri
Thomas Harding
P2860
P304
P356
10.1128/JVI.02561-08
P407
P577
2009-02-04T00:00:00Z